Lungs Home > Adcirca for Pulmonary Arterial Hypertension
Adcirca™ (tadalafil) is a medication prescribed to improve the ability to exercise in adults with pulmonary arterial hypertension (PAH). It is available in tablet form and is taken once a day. Potential side effects may include headaches, nausea, and heartburn.
Although it is not a cure for pulmonary arterial hypertension, Adcirca can help improve exercise ability by improving blood flow through the lungs.
Adcirca belongs to a group of medications called phosphodiesterase type-5 (PDE5) inhibitors, and works by causing the blood vessels in the lungs to relax in order to improve blood flow.
(To learn more about using this drug for pulmonary arterial hypertension, click Adcirca Uses. This article offers a complete overview of what this disease is, possible causes of it, and how this medication can help improve symptoms.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Adcirca [package insert]. Indianapolis, IN: Eli Lilly and Company;2009 May.
Tadalafil. Drug Facts and Comparisons. Drug Facts and Comparisons 4.0 [online]. 2010. Available from Wolters Kluwer Health, Inc. Accessed July 9, 2010.
Tadalafil. In DRUGDEX System. Thomson Reuters (Healthcare), Inc. Available at: http://www.thomsonhc.com. Accessed July 8, 2010.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click